[
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:2.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 15, 2022. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:20 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on May 01, 2021. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:24 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: August 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:21.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.58 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.93 sec. 9-hole peg non-dominant:22.41 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2020. Vit D at visit: 61.0. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.93 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.04 sec. 9-hole peg non-dominant:35.51 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2019. Tobacco smoker: ex-smoker  Vit D at visit: 75.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: June 24, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.26 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2019. Comments on DMT: Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:20.92 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2010. Comments on DMT: avonex. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 108.3. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 14, 2013. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:24 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.5 sec. 9-hole peg non-dominant:33 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on January 01, 2011. Comments on DMT: Cellcept, Other. The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on September 18, 2017. Comments on DMT: Rebif, Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 21. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Comments on DMT: atacicept, rebif, gilenya. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 13.6 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.78 sec. 9-hole peg non-dominant:20.78 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex, Betaferon (soped in 1\/Sep\/2013). Tobacco smoker: non-smoker  EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2017. Comments on DMT: Rebif. Vit D at visit: 48.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 03, 2018. The 25-foot walk done. 25-foot walk test time was 5.44 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 11. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 24, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 46.0. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.8 sec. 9-hole peg non-dominant:16.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: tecfidera. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. Vit D at visit: 25.2. The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.2 sec. 9-hole peg non-dominant:14.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Imuran ,Rebif, gilenya, endoxam cellcept. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 102 sec. SDMT done. SDMT numerator: 10. SDMT denominator: 10. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.03 sec. 9-hole peg non-dominant:133 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:17.42 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. Vit D at visit: 39.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). Remarks about MRI: Resolution of edema and decrease in size in C2 lesion. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:19.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 10, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.6 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.58 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.94 sec. 9-hole peg non-dominant:19.82 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Stopped during preg and breastfeeding on july 2020. Tobacco smoker: ex-smoker  Vit D at visit: 48.4. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:17.56 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on October 04, 2013. Comments on DMT: Avonex 2012-2013. Tobacco smoker: non-smoker  Vit D at visit: 48.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2014. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.682. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:rosacea . Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2019. Vit D at visit: 59.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2020. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.31 sec. 9-hole peg non-dominant:17.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on January 01, 2020. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. Exercise hrs per week:4. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:73 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2017. The 25-foot walk done. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.56 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:GAD, Social anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 35. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:20 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:18.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 02, 2020. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:1.49. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on May 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 70. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Cervical spine MRI date: September 01, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 2.5 sec. SDMT done. SDMT numerator: 82. SDMT denominator: 82. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2018. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 17, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.98 sec. 9-hole peg non-dominant:19.76 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Psychiatric disorders. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 30, 2016. Comments on DMT: Tecfidera (Jan 2015-May 2015\/0 Avonex (July 2015-Aug 2016). The 25-foot walk done. 25-foot walk test time was 5.19 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Avonex or Cinnovex- IM Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 05, 2022. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 43 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:84 sec. 9-hole peg non-dominant:55 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2013. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 17, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 81. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2019. Comments on DMT: tecfidera. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:17.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:lemtrada- alemtuzumab on March 23, 2016. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Coffee cups per week: 4. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 13, 2018. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:20.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: Avonex - Rebif. The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 24, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:34 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 24, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:21.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2015. Vit D at visit: 43.5. The 25-foot walk done. 25-foot walk test time was 4.86 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.56 sec. 9-hole peg non-dominant:24.16 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2015. Comments on DMT: rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Remarks about MRI: BASELINE MRI ON GILENYA. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.7 sec. 9-hole peg non-dominant:18.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 22.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: June 01, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 4. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.94 sec. 9-hole peg non-dominant:34 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.3. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on August 01, 2018. Comments on DMT: aubagio, rebif, gilenya, tysabri. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 78. SDMT denominator: 78. 9-HPT done.  9-hole peg dominant:14.3 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on October 15, 2021. Comments on DMT: Avonex, Gilenya, Tysabri. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.6 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on September 09, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.28 sec. 9-hole peg non-dominant:18.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Raynaud's Phenomenon. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on August 01, 2016. Vit D at visit: 93.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 14, 2019. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20.31 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1\/2 PPD. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2015. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.09 sec. 9-hole peg non-dominant:29.82 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. Comments on DMT: Rebif - Imuran - 5 sessions of plasma exchange in Oct 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 03, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 56.8 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:42.1 sec. 9-hole peg non-dominant:37.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:spms. There were new relapses since the previous visit. Comments on DMT: Avonex for 3m in 2003, Gilenya Mar 2012 till September 2012, Tysabri Feb 2013 till Mar 2013. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 5.5 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 10, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.81 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.95 sec. 9-hole peg non-dominant:15.53 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). IgG index in second:0.99. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 28, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:21.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2010. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 01, 2015. The 25-foot walk done. 25-foot walk test time was 4.95 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.34 sec. 9-hole peg non-dominant:26.51 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2010. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  -. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Vit D at visit: 50.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21.88 sec. 9-hole peg non-dominant:22.35 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Vitamin B 12 deficiency. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 10.15 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.9 sec. 9-hole peg non-dominant:31.68 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on December 01, 2014. The 25-foot walk done. 25-foot walk test time was 6.65 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.94 sec. 9-hole peg non-dominant:20.87 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2010. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.9 sec. 9-hole peg non-dominant:21.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on October 01, 2017. MRI of brain or spine done. Thoracic spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in  Thoracic spine: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2016. MRI of brain or spine done. Cervical spine MRI date: July 13, 2017. The 25-foot walk done. 25-foot walk test time was 3.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:24 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 18, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:21.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2001. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 9.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.9 sec. 9-hole peg non-dominant:31.3 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.99 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.25 sec. 9-hole peg non-dominant:24.04 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Vit D at visit: 66.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:24.4 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.27. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 01, 2022. Tobacco smoker: non-smoker  Coffee cups per week: 35. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:27 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on March 01, 2018. Comments on DMT: Avonex - Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 43 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Progression of disease. New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 52.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 04, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 9.95 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.13 sec. 9-hole peg non-dominant:34.01 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2023. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:19.85 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on February 01, 2020. Comments on DMT: Avonex, Tysabri. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35 sec. 9-hole peg non-dominant:35 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2022. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT: mabthera- rituximab. The 25-foot walk done. 25-foot walk test time was 67 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.5 sec. 9-hole peg non-dominant:29.58 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Avonex, Rebif, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:21.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2019. Comments on DMT: Rebif Avonex Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 44.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 04, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.96 sec. 9-hole peg non-dominant:18.12 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on November 07, 2014. Comments on DMT: Rebif sept 12 - oct 14. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Tobacco type: 1 PPD + arguileh daily. Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2020. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.25 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 56.0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.84 sec. 9-hole peg non-dominant:20.94 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. MRI of brain or spine done. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 27. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. Comments on DMT: Rebif - Avonex - Imuran. Tobacco smoker: non-smoker  Vit D at visit: 79.2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 20, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1ppd. Coffee cups per week: 21. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 06, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.17 sec. 9-hole peg non-dominant:18.11 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 56 months?",
        "output":"After 56 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on January 01, 2017. Comments on DMT: Betaferon - Tysabri - Aubagio. Vit D at visit: 47.0. The 25-foot walk done. 25-foot walk test time was 10.02 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.39 sec. 9-hole peg non-dominant:29 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:27 sec. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.33. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Retinal disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2007. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.11 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2019. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 27. DMT taken. Current DMT:mabthera- rituximab on August 01, 2015. The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.64 sec. 9-hole peg non-dominant:16.7 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Rebif (withheld now due to pregnancy). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.53 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2015. Vit D at visit: 6.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 18, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.03 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.54 sec. 9-hole peg non-dominant:17.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2015. Comments on DMT: Avonex Mar 2014\/Oct 2015. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.46 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.53 sec. 9-hole peg non-dominant:23.81 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.69. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Vit D at visit: 41.4. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.51. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: None . Tobacco smoker: non-smoker  Coffee cups per week: 2. Vit D at visit: 18.96. MRI of brain or spine done. Cervical spine MRI date: May 07, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:24.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2012. The 25-foot walk done. 25-foot walk test time was 3.55 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: February 10, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 99. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.12 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.83 sec. 9-hole peg non-dominant:26.29 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 45 months?",
        "output":"After 45 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Exercise hrs per week:2. Vit D at visit: 36.7. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:18.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 03, 2020. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.45 sec. 9-hole peg non-dominant:19.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: non-smoker  Coffee cups per week: 7. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.55 sec. 9-hole peg non-dominant:18.39 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2016. Comments on DMT: Rebif June 2016 until Sept 2016. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.58. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Rebif, Tecfidera. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 92. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:18.8 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 31, 2017. Comments on DMT: Tecfidera. Vit D at visit: 47.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 07, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on May 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 25, 2011. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT: mitoxantrone on October 01, 2019. Comments on DMT: Rituximab (1 dose). Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:19 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 21, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 1. Vit D at visit: 7.5. MRI of brain or spine done. Presence of new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20.52 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:83.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:hallux valgus surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total abdominal hysterectomy + bilateral salpingoopherectomy. Outcome:completely recovered from illness. Name of co-morbidity:Cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Head trauma. Outcome:completely recovered from illness. Name of co-morbidity:Right shoulder trauma. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Left wrist fracture. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 10 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 19. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:37 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 54.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: September 17, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:16.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 27, 2019. Comments on DMT: Tysabri. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 15.7 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:54 sec. 9-hole peg non-dominant:32 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:LABILE HTN. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Rebif. The patient is in EDA. Will the patient be in NEDA or EDA after 37 months?",
        "output":"After 37 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. Vit D at visit: 70.0. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 12.3 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.4 sec. 9-hole peg non-dominant:32 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 18, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 12, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 2. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on November 01, 2015. Comments on DMT: Dec 2013-Feb 2014 Gilenya, Jan 2015-Nov 2015 Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 54.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:32.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Tobacco smoker: non-smoker  Vit D at visit: 32.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 19, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:18.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:spms. Comments on DMT: Betaferon, Avonex, Rebif, cyclophosphamide . MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 12.4 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 15. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.4 sec. 9-hole peg non-dominant:42.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.49 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.36 sec. 9-hole peg non-dominant:20.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Lemtrada- Alemtuzumab. The patient is in EDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.607. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2022. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on March 01, 2023. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:15.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.4. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Vit D at visit: 31.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 06, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.66 sec. 9-hole peg non-dominant:18.67 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. Comments on DMT: Avonex, Betaferon(stoped in 1\/Sep\/2013). Tobacco smoker: non-smoker  Coffee cups per week: 35. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.5 sec. 9-hole peg non-dominant:22.62 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.26 sec. 9-hole peg non-dominant:16.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.91 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.1 sec. 9-hole peg non-dominant:34.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Tecfidera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: September 28, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left. 9-hole peg non-dominant:36.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.6 sec. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:44 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif, Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 16, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.43 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.34 sec. 9-hole peg non-dominant:29.21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:22.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:positive. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: aubagio. Vit D at visit: 18.92. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2019. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 9.7 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:24 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Right breast cancer. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:right shoulder tendinitis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2020. Comments on DMT: took gilenya from dec 2017- june 2020. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 01, 2021. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:22.54 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2021. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 01, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: HB Weekly. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:26 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on May 01, 2021. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 05, 2015. Comments on DMT: Betaferon (Dec 2012-June 2013), Tysabri (June 2013-Aug 2015). Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 57.6. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 4. Cervical spine MRI date: March 04, 2016. The 25-foot walk done. 25-foot walk test time was 4.33 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.17 sec. 9-hole peg non-dominant:21.84 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 895.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: July 29, 2019. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.2 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.89. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: one per week . Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:7. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. Comments on DMT: gilenya. Tobacco smoker: ex-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 03, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:19.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Aubagio- Teriflunomide. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 01, 2015. Tobacco smoker: non-smoker  Vit D at visit: 63.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.33 sec. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. Tobacco smoker: non-smoker  Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.78 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Vit D at visit: 80.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Cervical spine MRI date: February 11, 2020. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. The 25-foot walk done. 25-foot walk test time was 10.8 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.4 sec. 9-hole peg non-dominant:30 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2018. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 33.0. The 25-foot walk done. 25-foot walk test time was 3.27 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:19.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: REbif. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:44 sec. 9-hole peg non-dominant:21 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 23. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2020. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 36 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:26.1 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.08 sec. 9-hole peg non-dominant:20.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: avonex, rebif, cyclophosphamide . Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 56 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38 sec. 9-hole peg non-dominant:46 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on February 01, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Exercise hrs per week:3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 19, 2022. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.65 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 19, 2019. Comments on DMT: Rebif, avonex, aubagio. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:vestibular migraine. Total relapses until visit: 2. Tobacco smoker: non-smoker  Vit D at visit: 22.8. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2009. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 37 months?",
        "output":"After 37 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2011. Comments on DMT: Avonex. Vit D at visit: 8.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 13, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.87 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 89 months?",
        "output":"After 89 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 24.5. The 25-foot walk done. 25-foot walk test time was 23.54 sec. SDMT done. SDMT numerator: 16. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.88 sec. 9-hole peg non-dominant:31.66 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 100. SDMT denominator: 100. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:oophorectomy for ovrian teratoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Vit D at visit: 50.3. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:24 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 01, 2013. Comments on DMT: betaferon. Tobacco smoker: non-smoker  Vit D at visit: 18.0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 76.14 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.83 sec. 9-hole peg non-dominant:42.42 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: Tecfidera. The 25-foot walk done. 25-foot walk test time was 7.2 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.65 sec. 9-hole peg non-dominant:35.15 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 07, 2016. MRI of brain or spine done. Cervical spine MRI date: November 15, 2017. The 25-foot walk done. 25-foot walk test time was 5.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.7 sec. 9-hole peg non-dominant:31.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 8.12 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.38 sec. 9-hole peg non-dominant:40.33 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on August 27, 2015. Comments on DMT: None . MRI of brain or spine done. Cervical spine MRI date: September 29, 2016. The 25-foot walk done. 25-foot walk test time was 6.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:26.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 12, 2017. Comments on DMT: Rebif - Avonex- Betaseron. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.9 sec. 9-hole peg non-dominant:67.8 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2008. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA. Will the patient be in NEDA or EDA after 54 months?",
        "output":"After 54 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.01. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2017. Vit D at visit: 43.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:20.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2016. Vit D at visit: 23.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 13, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.22 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.99 sec. 9-hole peg non-dominant:23.74 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2018. Comments on DMT: rebif. Tobacco smoker: non-smoker  Vit D at visit: 42.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: betaferon, rituximab. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 172.8. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:22 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Comments on DMT: no. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 17, 2017. Whole spinal cord lesion load on MRI: No lesions. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on July 01, 2018. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:19.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT: rebif, atoricept trial . MRI of brain or spine done. Cervical spine MRI date: May 03, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 14.97 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.28 sec. 9-hole peg non-dominant:28.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT: cellcept and monthly ivig on May 01, 2011. Comments on DMT: Mabthera and monthly IVMP. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:6. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2018. Comments on DMT: Avonex, Recigen. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 12 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:24 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.7 sec. 9-hole peg non-dominant:26 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on July 05, 2022. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 2.6 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.53 sec. 9-hole peg non-dominant:19.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 25, 2012. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.25 PPD. Coffee cups per week: 21. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 11, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 06, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Name of co-morbidity:Anxiety. Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Comments on DMT: Gilenya, Imuran (Azathioprine), Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 49. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15.75 sec. 9-hole peg non-dominant:18.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2011. Tobacco smoker: non-smoker  Vit D at visit: 40.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:19.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, brainstem. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2014. The 25-foot walk done. 25-foot walk test time was 40.2 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.27. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 12.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 8.9 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.7 sec. 9-hole peg non-dominant:25.6 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. MRI of brain or spine done. Cervical spine MRI date: December 01, 2021. The 25-foot walk done. 25-foot walk test time was 7.3 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Tobacco smoker: non-smoker  EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. More information on co-morbidity:FMF. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:mog. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on December 04, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2018. Vit D at visit: 45.36. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2019. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2014. Comments on DMT: Avonex, Mabthera. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:18.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 56. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 14, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:22.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 89. SDMT denominator: 89. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.87 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 08, 2017. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 35 months?",
        "output":"After 35 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:17.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.47. IgG index category in CSF:Normal (< 0.77). IgG index in second:0.54. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.3 sec. 9-hole peg non-dominant:20.9 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 47 months?",
        "output":"After 47 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 98. SDMT denominator: 98. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 55.68. The 25-foot walk done. 25-foot walk test time was 4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:28.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 18, 2014. MRI of brain or spine done. Cervical spine MRI date: April 30, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on April 01, 2014. Comments on DMT: Betaferon, Imuran (Azathioprine). Tobacco smoker: non-smoker  Vit D at visit: 42.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:28.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:rpms vs spms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 28, 2015. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 10.43 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2005. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Vit D at visit: 32.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:24.21 sec. 9-hole peg non-dominant:20.47 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. The 25-foot walk done. 25-foot walk test time was 9.43 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.43 sec. 9-hole peg non-dominant:21.55 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2009. Comments on DMT: Rebif . MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2012. MRI of brain or spine done. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Copaxone - Betaferon - Mitoxantrone - Rebif. Vit D at visit: 29.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 28, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16.83 sec. SDMT done. SDMT numerator: 11. SDMT denominator: 14. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.12 sec. 9-hole peg non-dominant:50.14 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2009. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: October 10, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.35. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: imuran. Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 13.8 sec. SDMT done. SDMT numerator: 13. SDMT denominator: 13. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.8 sec. 9-hole peg non-dominant:40 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.96. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Vit D at visit: 58.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 27, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on December 10, 2014. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.17 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 18. Alcohol drinsk per week: 2. Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:18.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:5. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2016. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 12.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 27, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Lemtrada induced. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2016. Tobacco smoker: ex-smoker  Vit D at visit: 63.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 22, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.04 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.6 sec. 9-hole peg non-dominant:15.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. Comments on DMT: mitoxantrone. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 25.74 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:21.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Obstructive Sleep Apnea. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on December 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 14, 2016. The 25-foot walk done. 25-foot walk test time was 4.68 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.66 sec. 9-hole peg non-dominant:19.66 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 15, 2014. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:23.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 8. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.31 sec. 9-hole peg non-dominant:28 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2017. Comments on DMT: Betaferon; Tecfidera. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:25.5 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2015. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 39.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: October 31, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.74 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.95 sec. 9-hole peg non-dominant:18.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:5. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on March 13, 2017. Comments on DMT: Betaferon Gilenya Tysabri. The 25-foot walk done. 25-foot walk test time was 15.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:113 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.46. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:surgically-induced. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rosacea . Outcome:ongoing illness. Name of co-morbidity:Hyperprolactinemia . Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. MRI of brain or spine done. Thoracic spine MRI: Not compared to previous spine MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 6.7 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:33 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH s\/p TURP. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Constipation. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: Avonex; Betaseron; Rebif. Tobacco smoker: non-smoker  Vit D at visit: 88.6. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 42. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.7 sec. 9-hole peg non-dominant:70.74 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2016. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.6 sec. 9-hole peg non-dominant:19.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: monthly ivig on October 18, 2016. Comments on DMT: Avonex (2005-2007), Rebif (2007-2008), Betaferon (Sep 2009-July 2010), Tysabri (Aug 2010-Aug 2011), Gilenya (Nov 2012-June 2013), Mabthera (July 2013-July 2016). Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.01 PPD. Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.1 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.01 sec. 9-hole peg non-dominant:22.24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Monthly IV Ig. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2013. Comments on DMT: Betaferon (2009-2011) (discontinued due to persistent pancytopenia) Avonex (2011-Nov 2013) (discontinued due to clinical and radiological failure)  . Vit D at visit: 60.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.33. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Retinal disorders. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2007. Tobacco smoker: non-smoker  Vit D at visit: 34.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:25.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:neurosarcoidosis, initially thought rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.79. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:previously thought ms, but after v2 diagnosed with neurosarcoidosis. Comments on DMT: Avonex - Gilenya. Vit D at visit: 27.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.03 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.22 sec. 9-hole peg non-dominant:39.95 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.488. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2021. Comments on DMT: None . The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:67.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on August 27, 2015. MRI of brain or spine done. Cervical spine MRI date: January 19, 2016. The 25-foot walk done. 25-foot walk test time was 4.6 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 24.5. MRI of brain or spine done. Cervical spine MRI date: April 04, 2016. Cervical spine MRI: Not compared to previous spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.63 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:19.71 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.4 sec. 9-hole peg non-dominant:20.2 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 10, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 9.77 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.07 sec. 9-hole peg non-dominant:21.49 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.73. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 29, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:21.3 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2014. Comments on DMT: Gilenya - Cyclophosphamide. Vit D at visit: 50.5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:23.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Bell's Palsy. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on March 01, 2014. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 81 sec. SDMT done. SDMT numerator: 8. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:54 sec. 9-hole peg non-dominant:48 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2015. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 06, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 20, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.08 sec. SDMT done. SDMT numerator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.54 sec. 9-hole peg non-dominant:35.06 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2002. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2015. Tobacco smoker: ex-smoker  Exercise hrs per week:4. Vit D at visit: 62.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 21, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.4 sec. 9-hole peg non-dominant:23.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: January 01, 2021. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.28 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. Comments on DMT: betaferon, . Tobacco smoker: ex-smoker  Coffee cups per week: 56. Exercise hrs per week:5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.56 sec. 9-hole peg non-dominant:16.72 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: cellcept or imuxigen- mycophenolate. Comments on DMT: Betaferon - Mabthera - Monthly steroids. MRI of brain or spine done. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 11.5 sec. SDMT done. SDMT numerator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:22.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:1.04. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Comments on DMT: Rebif - Avonex. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:27.3 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 34 months?",
        "output":"After 34 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.8 sec. 9-hole peg non-dominant:29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: Betaferon, Immuran, Gilenya. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 6.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:24.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2017. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: current  Tobacco type: water-pipe. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.13 sec. 9-hole peg non-dominant:24.38 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, incidental mri findings. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 3. Vit D at visit: 75.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 06, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 3. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.06 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.09 sec. 9-hole peg non-dominant:22.87 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 49.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.18 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:66.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2004. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.78 sec. 9-hole peg non-dominant:20.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 4. There were new relapses since the previous visit. Comments on DMT: Avonex - Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. Vit D at visit: 95.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 8. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: July 25, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 8.8 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:23.4 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Number of attacks until the first visit:2. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Betaferon, Cellcept, Methotrexate. 9-HPT done. 9-HPT ability: unable with both hands. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in NEDA. Will the patient be in NEDA or EDA after 31 months?",
        "output":"After 31 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 2.3 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.15 sec. 9-hole peg non-dominant:23.14 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. Comments on DMT: methotrexate. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 14.3 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.51 sec. 9-hole peg non-dominant:26.77 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 28, 2015. Comments on DMT: Betaferon. Tobacco smoker: ex-smoker  Vit D at visit: 34.6. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 12.6 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:30 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Tobacco smoker: ex-smoker  Vit D at visit: 49.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:14.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2020. Tobacco smoker: non-smoker  Coffee cups per week: 28. Exercise hrs per week:8. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.43 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.62 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:20.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 4. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.66 sec. 9-hole peg non-dominant:25.56 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2017. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2015. Tobacco smoker: non-smoker  Vit D at visit: 79.8. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.7 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 01, 2017. Comments on DMT: rebif. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2019. Comments on DMT: Tecfidera, Gilenya. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.63 sec. 9-hole peg non-dominant:31.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:mog disease. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on December 04, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 27, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Both enhancing and non-enhancing lesions. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 7.6 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.02 sec. 9-hole peg non-dominant:26.74 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2017. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 50.3. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.37 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rash. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.6 sec. 9-hole peg non-dominant:22.8 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on October 18, 2017. Comments on DMT: gilenya, augbaio, tecfidera. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 61.0. The 25-foot walk done. 25-foot walk test time was 8.9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.7 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2022. The 25-foot walk done. SDMT done. SDMT numerator: 43. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:22 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Avonex, Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 16, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 95. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.1 sec. 9-hole peg non-dominant:22.04 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2021. Tobacco smoker: non-smoker  EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Mavenclad- Cladribine. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:14.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 15, 2021. The 25-foot walk done. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:23 sec. Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:negative. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:DVT. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2015. Comments on DMT: Interferons - Tecfidera - Tysabri. Vit D at visit: 99.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 30, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 3. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:50 sec. 9-hole peg non-dominant:54 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Lemtrada- Alemtuzumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on December 01, 2019. Comments on DMT: Rebif, Tecfidera, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: July 20, 2021. The 25-foot walk done. 25-foot walk test time was 2.7 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.6 sec. 9-hole peg non-dominant:14.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 27 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:60 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 18, 2007. The patient is in EDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 0. Comments on DMT: Rebif. Vit D at visit: 89.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 05, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 31, 2023. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:14.81 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Comments on DMT: Rebif (2006-2008), Betaferon (2008-June 2013). Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. Vit D at visit: 37.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.38 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:20.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2017. Comments on DMT: rebif, gilenya. MRI of brain or spine done. No new lesions on Brain MRI. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:15 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 21, 2018. Vit D at visit: 61.47. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 02, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.25 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:15.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on December 18, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 15, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.28 sec. SDMT done. SDMT numerator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:21.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: aubagio- teriflunomide. Comments on DMT: betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2016. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 18. SDMT denominator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.2 sec. 9-hole peg non-dominant:34.55 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.28. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Reflex trial, Rebif, aubagio. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Vit D at visit: 33.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 10, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 94. SDMT denominator: 95. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.49 sec. 9-hole peg non-dominant:20.06 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:carotid stenosis. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 06, 2018. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 11.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:23.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 21, 2011. Comments on DMT: Avonex 2008-2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: once weekly. The 25-foot walk done. 25-foot walk test time was 4.41 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.16 sec. 9-hole peg non-dominant:24.84 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2016. Vit D at visit: 52.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 30, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:20.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2018. Vit D at visit: 66.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 80. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.56 sec. 9-hole peg non-dominant:18.94 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2016. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 8.75 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.97 sec. 9-hole peg non-dominant:23.48 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 20, 2012. Tobacco smoker: current  Tobacco type: marijuana. Alcohol drinsk per week: 1. Vit D at visit: 35.6. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:21.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:TB. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Exercise hrs per week:1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: March 15, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. Vit D at visit: 38.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 13, 2016. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.7 sec. 9-hole peg non-dominant:23.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2022. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: No lesions. Cervical spine MRI date: June 22, 2023. The 25-foot walk done. 25-foot walk test time was 10.7 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 22. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:29 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:patellofemoral degeneration of left knee s\/p debridment of articular cartilage. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:septic arthritis of left knee. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:mild psoriasis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: June 19, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.98 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.13 sec. 9-hole peg non-dominant:26.46 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex . Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Exercise hrs per week:7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.31 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.79 sec. 9-hole peg non-dominant:16.95 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on October 09, 2019. Comments on DMT: None . The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on June 01, 2010. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 47.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 25, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.6 sec. 9-hole peg non-dominant:21.54 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:cis. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: August 25, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.92 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 11.37 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 31. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.7 sec. 9-hole peg non-dominant:33.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. Comments on DMT: Avonex. Vit D at visit: 15.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.74 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.44 sec. 9-hole peg non-dominant:24.83 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 40 months?",
        "output":"After 40 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Obstructive Sleep Apnea. Outcome:ongoing illness. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 04, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.37 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.95 sec. 9-hole peg non-dominant:16.54 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2013. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 24, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on August 26, 2016. Comments on DMT: patient preference : taking it once per year 500 mg . Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:29.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5ppd. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: December 30, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.6 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:20.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: April 17, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Gilenya. Vit D at visit: 86.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: January 10, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 10.3 sec. SDMT done. SDMT numerator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:25.6 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: April 17, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:RL fracture s\/p surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 21, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Gilenya. Vit D at visit: 15.6. The 25-foot walk done. 25-foot walk test time was 6.51 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.94 sec. 9-hole peg non-dominant:28.83 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 27 months?",
        "output":"After 27 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on November 05, 2015. Comments on DMT: Betaferon (Dec 2012-June 2013), Tysabri (June 2013-Aug 2015). Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 per day. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: October 13, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.49 sec. 9-hole peg non-dominant:27.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 19, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 36. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.01 sec. 9-hole peg non-dominant:40.37 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 36. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.68 sec. 9-hole peg non-dominant:22.97 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 3.16 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.47 sec. 9-hole peg non-dominant:25.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Surgeries. More information on co-morbidity:oophorectomy for ovrian teratoma. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 10, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.18 sec. SDMT done. SDMT numerator: 66. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:21.16 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:43.5 sec. 9-hole peg non-dominant:20.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 22, 2018. Comments on DMT: rebif, tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 68.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: November 19, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:15.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2014. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on January 01, 2017. Comments on DMT: Betaferon. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: June 08, 2017. The 25-foot walk done. 25-foot walk test time was 28 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.09 sec. 9-hole peg non-dominant:83.61 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2016. Comments on DMT: rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 26, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:27.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:lemtrada- alemtuzumab on April 01, 2016. Comments on DMT: betaferon. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.77 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:41.5 sec. 9-hole peg non-dominant:23.64 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:17.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on December 01, 2021. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.52 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 02, 2019. The 25-foot walk done. 25-foot walk test time was 3.22 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.77 sec. 9-hole peg non-dominant:21.07 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: 2002-2005: Avonex; 2005 - dec 2013: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. Vit D at visit: 107.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 29, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 23 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:49 sec. 9-hole peg non-dominant:49.7 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:opioid use disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 20. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 01, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.4 sec. 9-hole peg non-dominant:26.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:5. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2008. Comments on DMT: Rebif (2006-2008). Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 42. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 27, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:22.2 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. OCBs in CSF:positive. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.61 sec. 9-hole peg non-dominant:16.61 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:knee surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:appendenctomy. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 16, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5ppd . Vit D at visit: 53.0. MRI of brain or spine done. Cervical spine MRI date: April 15, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.45 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2011. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 3.18 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 28, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:27.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 18, 2018. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 41.2. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 9.41 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:27 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 44. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 07, 2014. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 05, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:22.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2017. The 25-foot walk done. 25-foot walk test time was 16.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.12 sec. 9-hole peg non-dominant:33.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Transurethra resenction of bladder tumor. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Right double J insertion and laser stone fragmentation. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Colonic polyps and diverticula. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on October 01, 2014. Vit D at visit: 53.7. The 25-foot walk done. 25-foot walk test time was 3.92 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:27.1 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.64. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Anti-MOG Abs seropositivity: Negative. Anti-MOG Abs denominator titer: 1:10. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 03, 2022. Cervical spine MRI: Not compared to previous spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.76. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on October 01, 2022. The 25-foot walk done. 25-foot walk test time was 4.19 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.2 sec. 9-hole peg non-dominant:24 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 62.0. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 26, 2020. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.14 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27.7 sec. 9-hole peg non-dominant:22.8 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 20, 2015. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: No lesions. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 8.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.56 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:21.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:73.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Vit D at visit: 68.0. The 25-foot walk done. 25-foot walk test time was 16.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:24.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex - Betaferon. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.71 sec. SDMT done. SDMT numerator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.25 sec. 9-hole peg non-dominant:27.51 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 7. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 7.78 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.46 sec. 9-hole peg non-dominant:44.59 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:hydronephrosis . Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:sinusitis . Name of co-morbidity:Surgeries. More information on co-morbidity:c section, sinus surgery, external fixation of ankle fracture. Outcome:completely recovered from illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. The 25-foot walk done. 25-foot walk test time was 4.46 sec. SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:19.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.16. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.24 sec. 9-hole peg non-dominant:18.21 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 18, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Coffee cups per week: 21. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:19.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 24, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 8 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:21.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: June 22, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 01, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:22.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 09, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:81.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Name of co-morbidity:Trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Cellulitis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 7. Comments on DMT: Rebif 1999-2007, avonex. Tobacco smoker: non-smoker  The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Comments on DMT: Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.76 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.66 sec. 9-hole peg non-dominant:20.19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2016. Comments on DMT: Rebif, Tecfidera. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 02, 2022. Tobacco smoker: non-smoker  Exercise hrs per week:5. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: recigen on September 01, 2015. Vit D at visit: 45.46. The 25-foot walk done. 25-foot walk test time was 4.75 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.77 sec. 9-hole peg non-dominant:30.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 25. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.3 sec. 9-hole peg non-dominant:29.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on October 29, 2018. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:77.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH . Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Disk disease. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Tinea versicolor. Outcome:completely recovered from illness. Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Rebif - Betaseron - Imuran - Po Prednisone. Tobacco smoker: non-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 60 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.62 sec. 9-hole peg non-dominant:35.34 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:varicella neuritis . Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:26 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Plegridy (September 2019 - Jan 2022, d\/c due to unavailability). MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Comments on DMT: avonex, rebif, gilenya. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.31 sec. 9-hole peg non-dominant:16.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2019. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 30, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 2. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.79 sec. 9-hole peg non-dominant:22.94 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:neurosarcoidosis, initially thought rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.79. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:previously thought ms, but after v2 diagnosed with neurosarcoidosis. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Avonex - Gilenya. The patient is in NEDA. Will the patient be in NEDA or EDA after 50 months?",
        "output":"After 50 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Visit diagnosis:rrms. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2013. Vit D at visit: 93.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 21, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:0. OCBs in CSF:positive. IgG index in CSF:0.64. Visit diagnosis:ris. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. MRI of brain or spine done. Cervical spine MRI date: September 22, 2017. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Visit diagnosis:cis. Comments on DMT: Avonex . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 22, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Allergies. More information on co-morbidity:penicillin. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:lumpectomy. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:fibroid resection. Outcome:completely recovered from illness. Visit diagnosis:ppms. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.08 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.14 sec. 9-hole peg non-dominant:18.63 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Vit D at visit: 18.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: October 17, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:22.4 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2009. Comments on DMT: Avonex. MRI of brain or spine done. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on March 01, 2014. Tobacco smoker: non-smoker  The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.69. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 28, 2019. MRI of brain or spine done. Thoracic spine MRI: Not compared to previous spine MRI. Whole spinal cord lesion load on MRI: No lesions. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2017. Comments on DMT: None . MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:SLE (Systemic Lupus Erythemat. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:spms. Comments on DMT: Rebif - Rituximab. The 25-foot walk done. 25-foot walk test time was 16.62 sec. SDMT done. SDMT numerator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.01 sec. 9-hole peg non-dominant:22.22 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:endoxan- cyclophosphamide on April 01, 2013. Comments on DMT: Betaseron - Avonex - Rebif - Imuran. The 25-foot walk done. 25-foot walk test time was 11.3 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Vit D at visit: 13.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.8 sec. 9-hole peg non-dominant:26 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on September 15, 2014. Comments on DMT: Betaferon June 2006-Aug 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 18, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.42 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.14 sec. 9-hole peg non-dominant:21.85 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.73. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2021. Tobacco smoker: ex-smoker  Vit D at visit: 59.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2021. Received Gadolinium for Cervical spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. Name of co-morbidity:Skin disorder. More information on co-morbidity:Psoriasis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 14. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 25, 2014. Tobacco smoker: ex-smoker  Coffee cups per week: 14. Exercise hrs per week:4. Vit D at visit: 25.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 20, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.6 sec. 9-hole peg non-dominant:27.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on November 01, 2011. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on February 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: September 15, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 9.6 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.88 sec. 9-hole peg non-dominant:18.46 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. Comments on DMT: betaferon, plegridy. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 06, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Plegridy (peginterferon beta 1-a). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: September 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:22.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on May 01, 2023. Comments on DMT: Cladribine in 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 21. Alcohol drinsk per week: 3. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: August 01, 2023. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 27, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Cervical spine MRI date: March 21, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.79 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.05 sec. 9-hole peg non-dominant:24.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 0. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 03, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 6.4 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.7 sec. 9-hole peg non-dominant:33.7 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on November 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.2 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: cyclophosphamide, rebif, avonex. Tobacco smoker: non-smoker  Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 40.67 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.25 sec. 9-hole peg non-dominant:30.95 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Name of co-morbidity:hypoxic brain injury. Name of co-morbidity:strabismus. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. Vit D at visit: 14.4. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 12, 2018. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2017. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 47.0. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mavenclad- cladribine on July 01, 2020. Comments on DMT: Tecfidera, Rebif. Tobacco smoker: non-smoker  Vit D at visit: 55.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: May 30, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:24.56 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:1. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Vit D at visit: 47.9. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Hypnagogic myoclonus. Outcome:ongoing illness. Name of co-morbidity:Chronic hepatitis B. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. Tobacco smoker: non-smoker  Vit D at visit: 34.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: September 01, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.7 sec. 9-hole peg non-dominant:21.24 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female. . Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.84. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2017. Comments on DMT: rebif, avonex. Vit D at visit: 70.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: September 25, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.2 sec. 9-hole peg non-dominant:30.5 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 59.5. The 25-foot walk done. 25-foot walk test time was 3.56 sec. SDMT done. SDMT numerator: 110. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.04 sec. 9-hole peg non-dominant:17.11 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.25. Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2019. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 65 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on April 01, 2014. Comments on DMT: Betaferon, Imuran. Tobacco smoker: non-smoker  Vit D at visit: 55.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 13, 2017. The 25-foot walk done. 25-foot walk test time was 5.3 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:24.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 01, 2015. Comments on DMT: Cellcept, Cinnovex, Rebif. The 25-foot walk done. 25-foot walk test time was 5.42 sec. SDMT done. SDMT numerator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:19.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.49. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:HEPATITIS C infection. Outcome:ongoing illness. Visit diagnosis:nmo. Total relapses until visit: 3. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.95. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on August 01, 2012. Tobacco smoker: non-smoker  Vit D at visit: 88.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 21, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 2. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.35 sec. 9-hole peg non-dominant:24.36 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:21.2 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Comments on DMT: Betaferon - Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:14.68 sec. 9-hole peg non-dominant:16.93 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on March 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: May 29, 2023. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:36 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 01, 2013. Comments on DMT: imuran 2004-Apr 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2011. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: February 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.4 sec. 9-hole peg non-dominant:28.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:lemtrada- alemtuzumab on January 26, 2016. Comments on DMT: Betaferon . MRI of brain or spine done. Cervical spine MRI date: July 22, 2016. The 25-foot walk done. 25-foot walk test time was 4.6 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index in CSF:1.02. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:SLE (Systemic Lupus Erythemat. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:rrms. Comments on DMT: Rebif- Rituximab . MRI of brain or spine done. Cervical spine MRI date: September 16, 2015. The 25-foot walk done. 25-foot walk test time was 15.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.1 sec. 9-hole peg non-dominant:26.4 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. Comments on DMT: Avonex (Jan 2015 - Mar 2015) failed with an attack Rebif (Mar 2015 - July 2015) failed with an attack Gilenya (Aug 2015 - April 2017) due to pregnancy was D\/C  . EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 06, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 19, 2022. The 25-foot walk done. 25-foot walk test time was 7.1 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:45.3 sec. 9-hole peg non-dominant:20.1 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:neuromyelitis . Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. The patient is in EDA. Will the patient be in NEDA or EDA after 242 months?",
        "output":"After 242 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    }
]